Preferred Label : ACTG1 wt Allele;

NCIt synonyms : Actin Gamma 1 wt Allele; HEL-176; ACT; DFNA20; Actin, Cytoplasmic, 2 Gene; ACTG; Deafness, Autosomal Dominant 26 Gene; DFNA26; Actin, Gamma Gene; Deafness, Autosomal Dominant 20 Gene; Deafness, Autosomal Dominant 20/26 Gene;

NCIt definition : Human ACTG1 wild-type allele is located in the vicinity of 17q25.3 and is approximately 44 kb in length. This allele, which encodes actin, cytoplasmic 2 protein, is involved in cell motility. Mutation of the gene is associated with autosomal dominant non-syndromic sensorineural progressive hearing loss and Baraitser-Winter syndrome.;

NCI Metathesaurus CUI : CL551892;

GenBank Accession Number : NM_001614;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3508235/fr/avis-n2024-0021/ac/sed-du-11-avril-2024-du-college-de-la-haute-autorite-de-sante-relatif-au-projet-d-arrete-limitant-la-pratique-de-l-acte-de-pose-de-valves-et-spirales-intrabronchiques-par-endoscopie-a-certains-etablissements-de-sante-en-application-de-l-article-l-1151-1-du-code-de-la-sante-publique
2024
France
health technology assessment
Projection
Loss of Chromosome 11
Regulatory Authority
Activated Coagulation Time
Potting
ACTG2 wt Allele
Limited
April
Endoscopic Procedure
Intrabronchial Route of Administration
GDC AJCC Clinical T Terminology
Limited Walking Ability
judgment
Extremities
schools
Nano
Projected
spiral
public health
attention
College Completion
health facilities
Neither Agree or Disagree
Computer Application
application, nos
Public Health
endoscopy, nos
attitude to health
ACTG1 wt Allele
Coil Device
Application
Adoptive Immunotherapy
endoscopy
Established
Asthma Control Test Questionnaire
N
Relative Value
Application Method of Administration
SERPINA3 wt Allele
Stopcock Valve Device
N Category
Signal to Noise Ratio
Alpha-1-Antichymotrypsin
Eleven
Cyclophosphamide/Doxorubicin/Tamoxifen
Periodontal Screening and Recording Code 1
Newton
No
Application
Splayed
Tumor to Normal
Convolution
medical futility
MATCH Arm EAY131-N
Limiter Device
Limited Lifting Ability

---
https://www.reiso.org/articles/themes/soins/11843-une-therapie-a-domicile-apres-un-acte-suicidaire
2023
Switzerland
popular works
domicile
Status Post
therapy, nos
ACTG2 wt Allele
During or After
residence characteristics
GDC AJCC Clinical T Terminology
Activated Coagulation Time
Asthma Control Test Questionnaire
SERPINA3 wt Allele
Papaverine Hydrochloride
Alpha-1-Antichymotrypsin
Cyclophosphamide/Doxorubicin/Tamoxifen
ACTG1 wt Allele
Adoptive Immunotherapy

---
Nous contacter.
29/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.